Search research articles
Contact Us
Filters
Showing results (81-90 of 122) with videos related to
Page
of 13
Sort By:
Journal of Clinical Medicine
|
February 15, 2022
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Aurora Nicolosi, et al.
Current Oncology (Toronto, Ont.)
|
August 25, 2022
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
Gian Paolo Caviglia, Aurora Nicolosi, Maria Lorena Abate, et al.
International Journal of Molecular Sciences
|
January 21, 2023
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Giorgia Colombo, Chiara Rosso, et al.
Minerva Gastroenterology
|
October 12, 2022
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma
Aurora Nicolosi, Silvia Gaia, Alessandra Risso, et al.
Journal of Clinical Medicine
|
January 21, 2023
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Ramy Younes, et al.
Journal of Clinical Medicine
|
March 19, 2020
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
Gian Paolo Caviglia, Chiara Rosso, Francesco Stalla, et al.
The American Journal of Gastroenterology
|
June 11, 2025
Impact of MASLD and associated comorbidities on Cognitive and Health-related Quality of Life outcomes in a Mixed MASLD-T2DM Cohort
Nuria Perez-Diaz-Del-Campo, Gabriele Castelnuovo, Arianna Ferro, et al.
Cancers
|
November 4, 2020
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology
Gian Paolo Caviglia, Michela Ciruolo, Maria Lorena Abate, et al.
Journal of Personalized Medicine
|
June 27, 2024
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility
Nicola Pugliese, Davide Polverini, Rosa Lombardi, et al.
European Journal of Clinical Investigation
|
February 24, 2024
Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis
Ovidio De Filippo, Gianluca Di Pietro, Marco Nebiolo, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 122) with videos related to
Sort By:
Page
of 13
Journal of Clinical Medicine
|
February 15, 2022
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Aurora Nicolosi, et al.
Current Oncology (Toronto, Ont.)
|
August 25, 2022
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
Gian Paolo Caviglia, Aurora Nicolosi, Maria Lorena Abate, et al.
International Journal of Molecular Sciences
|
January 21, 2023
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Giorgia Colombo, Chiara Rosso, et al.
Minerva Gastroenterology
|
October 12, 2022
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma
Aurora Nicolosi, Silvia Gaia, Alessandra Risso, et al.
Journal of Clinical Medicine
|
January 21, 2023
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Ramy Younes, et al.
Journal of Clinical Medicine
|
March 19, 2020
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
Gian Paolo Caviglia, Chiara Rosso, Francesco Stalla, et al.
The American Journal of Gastroenterology
|
June 11, 2025
Impact of MASLD and associated comorbidities on Cognitive and Health-related Quality of Life outcomes in a Mixed MASLD-T2DM Cohort
Nuria Perez-Diaz-Del-Campo, Gabriele Castelnuovo, Arianna Ferro, et al.
Cancers
|
November 4, 2020
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology
Gian Paolo Caviglia, Michela Ciruolo, Maria Lorena Abate, et al.
Journal of Personalized Medicine
|
June 27, 2024
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility
Nicola Pugliese, Davide Polverini, Rosa Lombardi, et al.
European Journal of Clinical Investigation
|
February 24, 2024
Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis
Ovidio De Filippo, Gianluca Di Pietro, Marco Nebiolo, et al.
Page
of 13